scholarly article | Q13442814 |
P356 | DOI | 10.1001/JAMA.1974.03230420021019 |
P698 | PubMed publication ID | 4599980 |
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 409-418 | |
P577 | publication date | 1974-07-01 | |
P1433 | published in | The Journal of the American Medical Association | Q1470970 |
P1476 | title | Effect of antihypertensive treatment on stroke recurrence. Hypertension-Stroke Cooperative Study Group | |
P478 | volume | 229 |
Q28193940 | A benefit-risk assessment of agents used in the secondary prevention of stroke |
Q36776127 | A propensity-matched study of hypertension and increased stroke-related hospitalization in chronic heart failure |
Q40475907 | Acute cerebral infarction. Optimal management in older patients. |
Q56658918 | Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324 168 participants from randomised trials |
Q33871976 | Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group |
Q24186039 | Antihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individuals |
Q33910165 | Antihypertensive therapy for preventing cardiovascular complications in people with diabetes mellitus |
Q33768748 | Antihypertensive therapy in the prevention of stroke: what, when and for whom? |
Q47607397 | Association of Blood Pressure Lowering With Mortality and Cardiovascular Disease Across Blood Pressure Levels: A Systematic Review and Meta-analysis. |
Q69910653 | Benefits of treatment of mild to moderate hypertension |
Q33783596 | Blood Pressure Management for Stroke Prevention and in Acute Stroke |
Q37618329 | Blood pressure lowering treatment for preventing stroke recurrence: a systematic review and meta-analysis |
Q37607096 | Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature |
Q64977297 | Blood pressure targets for hypertension in patients with type 2 diabetes. |
Q57689006 | Blood pressure-lowering treatment for preventing recurrent stroke, major vascular events, and dementia in patients with a history of stroke or transient ischaemic attack |
Q37691484 | Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial |
Q43782892 | Cardiovascular protection and blood pressure reduction: a meta-analysis |
Q38245562 | Cardiovascular risks associated with diastolic blood pressure and isolated diastolic hypertension. |
Q37090522 | Clinical benefits of structural and functional changes with calcium antagonists |
Q72570518 | Clinical experiences in arterial hypertension in the elderly |
Q26747669 | Comparative Effectiveness of Blood Pressure-lowering Drugs in Patients who have Already Suffered From Stroke: Traditional and Bayesian Network Meta-analysis of Randomized Trials |
Q33577871 | Cost-effective intervention in stroke |
Q69466862 | Course of blood pressure after cerebral infarction and transient ischemic attack |
Q71223656 | Current status of risk factors for stroke |
Q40391892 | Do Non-Potassium-Sparing Diuretics Increase the Risk of Sudden Cardiac Death in Hypertensive Patients? |
Q22306359 | Effect of Antihypertensive Treatment in Patients Having Already Suffered From Stroke : Gathering the Evidence |
Q26766025 | Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses |
Q33722602 | Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials |
Q24239935 | First-line drugs for hypertension |
Q56336831 | First-line drugs for hypertension |
Q24794311 | Generalizability of guidelines and physicians' adherence. Case study on the Sixth Joint National Commitee's guidelines on hypertension |
Q34299778 | Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. |
Q40587863 | Guidelines for the treatment of hypertension: a critical review |
Q44696693 | Hypertension and Strokes |
Q71667553 | Hypertension and stroke |
Q93857498 | Hypertension in the elderly |
Q95402406 | Hypertension-current management: Part II |
Q39662529 | Hypertension—Current management: Part I |
Q40167377 | Influence of hypotensive drug treatment on morbidity and mortality in elderly hypertensives - review of the published trials |
Q34053343 | Lowering of blood pressure for recurrent stroke prevention |
Q41333277 | Management of hypertension in acute intracerebral hemorrhage |
Q33239013 | Methods underpinning national clinical guidelines for hypertension: describing the evidence shortfall |
Q66935789 | Microvascular neurosurgical arterial bypass for cerebral ischemia: A decade of development |
Q72566059 | Oxprenolol in the treatment of hypertension in the elderly |
Q40092109 | Pathophysiologic considerations in the treatment of the elderly hypertensive patient |
Q41388507 | Pathophysiology and treatment implications of hypertension in the African-American population |
Q38622305 | Pharmacotherapy for hypertension in adults aged 18 to 59 years. |
Q24240189 | Pharmacotherapy for hypertension in the elderly |
Q70664158 | Potassium and magnesium abnormalities: diuretics and arrhythmias in hypertension |
Q35635847 | Prevalence of stroke in three semi-urban communities in middle-belt region of Nigeria: a door to door survey |
Q74654793 | Prevention of Ischemic Stroke |
Q66915597 | Prevention of heart disease by control of risk factors: The time has come to face the facts |
Q28192311 | Prevention of ischemic stroke |
Q35656881 | Prognosis of Adequately Treated Hypertensive Patients |
Q28213134 | Progress in clinical neurosciences: pharmacotherapies for the secondary prevention of stroke |
Q37679290 | Review of the major hypertension trials in the elderly |
Q40977152 | Risk and management of hypertension-related left ventricular hypertrophy |
Q33897188 | Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials |
Q36554968 | Secondary prevention of stroke by blood pressure-lowering treatment. |
Q41440233 | Sudden cardiac death in patients with hypertension. An association with diuretics and beta-blockers? |
Q33696196 | Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug? |
Q92377672 | The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019) |
Q40802367 | The prevention of cardiovascular disease. Emphasis on secondary prevention. |
Q39570496 | The therapeutic dilemma of hypertension in the elderly |
Q42676664 | Thiazides in the management of hypertension in older adults - a systematic review. |
Q37078895 | Treatment of elderly hypertensive patients with epithelial sodium channel inhibitors combined with a thiazide diuretic reduces coronary mortality and sudden cardiac death |
Q41060513 | Treatment of post-stroke hypertension. A practical guide |
Q40493838 | Treatment of stroke in older patients. A state of the art review |
Q73373842 | [Hypertension in the elderly and health global results with different pharmacological therapies] |
Q79314852 | [Sequelae of hypertension on end-organs of the brain] |